These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3027448)

  • 1. Biochemical phenotyping of a single sibship with both cystinosis and Fabry disease.
    Gahl WA; Adamson M; Kaiser-Kupfer I; Ludwig IH; O'Connell HJ; Cohen W; Barranger J
    J Inherit Metab Dis; 1985; 8(3):127-31. PubMed ID: 3027448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fabry disease and cystinosis, two lysosomal diseases: similarities and differences].
    Grünfeld JP; Servais A
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S226-8. PubMed ID: 21211669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal cystine counter-transport in heterozygotes for cystinosis.
    Gahl WA; Bashan N; Tietze F; Schulman JD
    Am J Hum Genet; 1984 Mar; 36(2):277-82. PubMed ID: 6711558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal cystine transport in cystinosis variants and their parents.
    Gahl WA; Tietze F
    Pediatr Res; 1987 Feb; 21(2):193-6. PubMed ID: 3822600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry disease. Classic hemizygote and residual alpha-galactosidase A activity.
    Pravata G; Noto G; Arico M
    Int J Dermatol; 1991 May; 30(5):367-9. PubMed ID: 1648549
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.
    Gahl WA; Bashan N; Tietze F; Bernardini I; Schulman JD
    Science; 1982 Sep; 217(4566):1263-5. PubMed ID: 7112129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease.
    Auray-Blais C; Cyr D; Ntwari A; West ML; Cox-Brinkman J; Bichet DG; Germain DP; Laframboise R; Melançon SB; Stockley T; Clarke JT; Drouin R
    Mol Genet Metab; 2008 Mar; 93(3):331-40. PubMed ID: 18023222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease: a treatable lysosomal storage disorder.
    Phadke SR; Mandal K; Girisha KM
    Natl Med J India; 2009; 22(1):20-2. PubMed ID: 19761154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of nephropathic cystinosis. Pregnancy at risk ascertained through heterozygote diagnosis of parents.
    Boman H; Schneider JA
    Acta Paediatr Scand; 1981; 70(3):389-93. PubMed ID: 7246131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical comparisons of the adult and childhood forms of cystinosis.
    Schneider JA; Wong V; Bradley K; Seegmiller JE
    N Engl J Med; 1968 Dec; 279(23):1253-7. PubMed ID: 4880015
    [No Abstract]   [Full Text] [Related]  

  • 11. Benign cystinosis. The clinical, biochemical and morphologic findings in a family with two affected siblings.
    Brubaker RF; Wong VG; Schulman JD; Seegmiller JE; Kuwabara T
    Am J Med; 1970 Oct; 49(4):546-50. PubMed ID: 5477639
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
    Demontis R
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in our knowledge of cystinosis.
    Kroll W; Schneider JA
    Clin Endocrinol Metab; 1974 Mar; 3(1):57-69. PubMed ID: 4609649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical and pathological studies on a carrier of Fabry's disease manifesting bouts of pain in the extremities].
    Katayama M; Kobayashi T; Ohnishi A; Goto I; Kuroiwa Y
    Rinsho Shinkeigaku; 1984 Jun; 24(6):575-80. PubMed ID: 6094070
    [No Abstract]   [Full Text] [Related]  

  • 15. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.
    Redonnet-Vernhet I; Ploos van Amstel JK; Jansen RP; Wevers RA; Salvayre R; Levade T
    J Med Genet; 1996 Aug; 33(8):682-8. PubMed ID: 8863162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.
    Wang RY; Abe JT; Cohen AH; Wilcox WR
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S369-74. PubMed ID: 18937048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent cystinosis: a clinical and specular microscopic study of an unusual sibship.
    Dale RT; Rao GN; Aquavella JV; Metz HS
    Br J Ophthalmol; 1981 Dec; 65(12):828-32. PubMed ID: 7317329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted urine microscopy in Anderson-Fabry disease: a cheap, sensitive and specific diagnostic technique.
    Selvarajah M; Nicholls K; Hewitson TD; Becker GJ
    Nephrol Dial Transplant; 2011 Oct; 26(10):3195-202. PubMed ID: 21382994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent cystinosis: comparisons with infantile and adult forms.
    Goldman H; Scriver CR; Aaron K; Delvin E; Canlas Z
    Pediatrics; 1971 Jun; 47(6):979-88. PubMed ID: 5141767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.